Trial Profile

A Phase 2/3 study of BPM31510 in primary CoQ10 deficiency

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 10 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ubidecarenone (Primary)
Indications Cancer; Pancreatic cancer
Focus Registrational; Therapeutic Use

Most Recent Events

08 Oct 2024 According to a BPGbio, Inc. media release, company is planning phases for late-stage Phase 2/3 trial for PCQD.
30 Sep 2024 According to a BPGbio media release, the company is planning a potential pivotal trial of BPM31510IV targeting multiple CoQ10 deficiency mutations at multiple US and EU sites.
21 Jun 2024 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com